Methotrexate-associated lymphoproliferative disorder

研究成果: Article査読

4 被引用数 (Scopus)

抄録

Methotrexate-associated lymphproliferative disorder (MTX-LPD) is a rare but critical complication developing in patients treated with methotrexate. Now that methotrexate is an anchor drug in the management of rheumatoid arthritis and become commonly used, MTX-LPD cases have increased. Many things has been unclear such as incidence, demographic characters, and risk factors. However, as the researches increased, several interesting topics has been demonstrated like associations with Epsteiin-Barr virus and with cell-mediated immunity. This report reviews newly the latest findings and future challenges on MTX-LPD.

本文言語English
ページ(範囲)174-178
ページ数5
ジャーナルJapanese Journal of Clinical Immunology
40
3
DOI
出版ステータスPublished - 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

フィンガープリント 「Methotrexate-associated lymphoproliferative disorder」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル